Skip to main content

The Use of Adjuvants in Experimental Vaccines

IV. ISCOMS

  • Protocol
Vaccine Protocols

Part of the book series: Methods in Molecular Medicine™ ((MIMM,volume 4))

Abstract

The use of saponin in experimental vaccines has been known for more than 60 yr (1, Chapter 9) and generally it is more active as an adjuvant with strongly immunogenic antigens. A number of saponins are derived from the bark of the South American soaptree (Quillaja saponaria) as acylated triterpenoids each having quillaic acid as the aglycone but with different glycosidic side chains. From the crude preparations it has been possible to refine purer mixtures, e.g., Quil A (2) and QS-21 (3). These have been shown to exert an adjuvant effect at doses as low as 5.0–20.0 μg. Because a wide variety of foods contain saponins there is potential for their use in oral vaccines, but there has been some reluctance to use them parenterally because of their known membranolytic and hemolytic effects; ISCOMs have not been shown to possess hemolytm activity at the usual dose levels used in animals.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Campbell, J. B. (1994) Saponins, in The Theory and Practical Application of Adjuvants (Stewart-Tull, D. E. S., ed.), Wiley, Chichester and New York, pp. 95–127.

    Google Scholar 

  2. Dalsgaard K. (1978) A study of the isolation and characterization of the saponm Quil A: evaluation of its adjuvant activity, with special reference to the application in the vaccination of cattle agamst foot-and-mouth disease. Acta Vet. Stand. 19(Suppl. 69), 1–40.

    Google Scholar 

  3. Kensll, C. R., Patel, U., Lennick, M., and Marciani, D. (1991) Separation and characterization of saponins with adJuvant activity from Quillaja saponana Molina cortex. J. Immunol. 146, 43–437.

    Google Scholar 

  4. Claassen, I. and Osterhaus, A. (1992) The iscom structure as an immune enhancing moiety. experiences in viral systems. Res. Immunol. 143, 531–541.

    Article  PubMed  CAS  Google Scholar 

  5. Dalsgaard, K., Lovgren, K., and Stewart-Tull, D. E. S. (1994) Immune stimulating complexes with Quil A, in The Theory and Practical Application of Adjuvants (Stewart-Tull, D. E. S., ed.), Wiley, Chichester and New York, pp. 129–144.

    Google Scholar 

  6. Kersten, G. F. A, Sprekstra, A., Beuvery, E. C., and Crommelm, D. J. A. (1991) On the structure of immune-stimulating saponm-lipid complexes (ISCOMs). Blochim. Biophys. Acta 1062, 165–171.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Humana Press Inc, Totowa, NJ

About this protocol

Cite this protocol

Stewart-Tull, D.E.S. (1996). The Use of Adjuvants in Experimental Vaccines. In: Robinson, A., Farrar, G.H., Wiblin, C.N. (eds) Vaccine Protocols. Methods in Molecular Medicine™, vol 4. Humana Press. https://doi.org/10.1385/0-89603-334-1:153

Download citation

  • DOI: https://doi.org/10.1385/0-89603-334-1:153

  • Publisher Name: Humana Press

  • Print ISBN: 978-0-89603-334-4

  • Online ISBN: 978-1-59259-588-4

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics